Stocks and Investing
Stocks and Investing
Mon, January 11, 2016
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
Sun, January 10, 2016
[ 12:00 AM ] - WOPRAI
Fri, January 8, 2016
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
Thu, January 7, 2016
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
Wed, January 6, 2016
Maury Raycroft Upgraded (BCRX) to Strong Buy and Held Target at $14 on, Jan 6th, 2016
Maury Raycroft of Jefferies, Upgraded "BioCryst Pharmaceuticals, Inc." (BCRX) to Strong Buy and Held Target at $14 on, Jan 6th, 2016.
Maury has made no other calls on BCRX in the last 4 months.
There is 1 other peer that has a rating on BCRX. Out of the 1 peers that are also analyzing BCRX, 0 agree with Maury's Rating of Hold.
This is the rating of the analyst that currently disagrees with Maury
- Tazeen Ahmad of "B of A Securities" Downgraded from Hold to Sell on, Wednesday, November 11th, 2015